NCT06507475View on ClinicalTrials.gov

Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type 2 Diabetes

Not yet recruitingOBSERVATIONAL

Enrollment

209

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

January 15, 2025

Study Completion Date

January 15, 2025

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Semaglutide

Participants treated with commercially available oral semaglutide according to local label and to routine clinical practice at the discretion of the treating physician.